Clinical Trials Browser

Phase 2 × Glioblastoma × balstilimab × Clear all

NCT05864534 2025-10-03

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Phase 2 Recruiting

Glioblastoma, Gliosarcoma